Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Hepatocellular Carcinoma”

501 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 501 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Not applicableStudy completedNCT06856590
What this trial is testing

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

Who this might be right for
Hand-Foot Skin Reaction (HFSR)
Gazi University 150
Testing effectiveness (Phase 2)Study completedNCT00519688
What this trial is testing

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 44
Testing effectiveness (Phase 2)UnknownNCT05903456
What this trial is testing

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT02181075
What this trial is testing

Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours

Who this might be right for
Liver Tumour
University of Oxford 10
Large-scale testing (Phase 3)Study completedNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 479
Not applicableStudy completedNCT00482586
What this trial is testing

Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Who this might be right for
Liver CancerMetastatic Cancer
Vanderbilt University 137
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT03741088
What this trial is testing

Study to Evaluate VORTX Rx (Theresa)

Who this might be right for
Carcinoma, HepatocellularLiver Metastases
HistoSonics, Inc. 8
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00976170
What this trial is testing

Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Hepatocellular Carcinoma
Chugai Pharmaceutical 42
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Looking for participantsNCT03895359
What this trial is testing

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Who this might be right for
Hepatocellular Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Early research (Phase 1)Study completedNCT01628640
What this trial is testing

Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmHepatocellular Carcinoma
Mayo Clinic 17
Testing effectiveness (Phase 2)Looking for participantsNCT07523529
What this trial is testing

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Who this might be right for
Advanced UnresectableMetastatic
Beijing Biotech 72
Large-scale testing (Phase 3)Looking for participantsNCT06109272
What this trial is testing

Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AbbVie 660
Testing effectiveness (Phase 2)Study completedNCT00191412
What this trial is testing

Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

Who this might be right for
Liver Cancer
Eli Lilly and Company 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07328802
What this trial is testing

Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma

Who this might be right for
ORR,OS,PFS
Second Affiliated Hospital, School of Medicine, Zhejiang University 25
Load More Results